About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

The study revealed the following findings: 36.3% of psoriasis patients had elevated high-sensitivity C-reactive protein ...

Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

Among 25 different measures of adiposity, abdominal fat was significantly associated with a risk for psoriasis. Among 25 ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

The study reveals that patients with both T2D and psoriasis face a significantly elevated risk of developing renal conditions ...

A new study highlights a significant medical concern for individuals suffering from psoriasis, revealing that even when skin ...

Biocon share rose after arm, Biocon Biologics, was granted market authorisation in the UK for Yesintek, a biosimilar of ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

The "Saudi Arabia Dermatological Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd (BSE: 532520, today announced that the UK’s ...